# BMEA (Biomea Fusion, Inc.) - SEC EDGAR Financial Statements

> Biomea Fusion, Inc. reported $28.10M in total assets and a net loss of $22.31M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BMEA
- Markdown: https://convexityos.com/fundamentals/BMEA.md
- SEC CIK: 0001840439
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:00 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001840439&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$50.22M | Operating profit |
| Net Income | FY 2025 | -$22.31M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.31 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $26.40M | Total debt: $506K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $61.98M | $118.1M | $102.5M | $62.71M | $28.00M | $3.67M | $1.09M |
| Total Operating Expenses | $83.51M | $144.1M | $126.1M | $83.63M | $41.67M | $5.33M | $1.20M |
| **Operating Income** | -$83.51M | -$144.1M | -$126.1M | -$83.63M | -$41.67M | -$5.33M | -$1.20M |
| **EBITDA** | -$82.10M | -$142.3M | -$124.6M | -$82.94M | -$41.42M | -$5.32M | -$1.20M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| **Net Income** | -$61.80M | -$138.4M | -$117.3M | -$81.83M | -$41.57M | -$5.32M | -$1.20M |
| Basic EPS | -$1.18 | -$3.83 | -$3.44 | -$2.80 | -$1.74 | -$0.51 | -$0.20 |
| **Diluted EPS** | -$1.18 | -$3.83 | -$3.44 | -$2.80 | -$1.74 | -$0.51 | -$0.20 |
| Basic Shares Outstanding | 52.2M | 36.1M | 34.1M | 29.3M | 23.9M | 10.5M | 6.1M |
| Diluted Shares Outstanding | 52.2M | 36.1M | 34.1M | 29.3M | 23.9M | 10.5M | 6.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $8.53M | $9.14M | $9.12M | $8.12M | $14.40M | $16.57M | $22.90M | $25.24M |
| Total Operating Expenses | $12.96M | $12.77M | $12.77M | $11.72M | $20.80M | $21.28M | $29.71M | $30.07M |
| **Operating Income** | -$12.96M | -$12.77M | -$12.77M | -$11.72M | -$20.80M | -$21.28M | -$29.71M | -$30.07M |
| **EBITDA** | -$12.95M | -$12.75M | -$12.73M | -$11.67M | -$20.41M | -$20.78M | -$29.24M | -$29.61M |
| **Net Income** | -$6.18M | -$8.33M | -$12.41M | $4.61M | -$16.41M | -$20.74M | -$29.26M | -$29.30M |
| Basic EPS | -$0.09 | -$0.12 | -$0.17 | -- | -$0.27 | -$0.51 | -$0.80 | -$0.81 |
| **Diluted EPS** | -$0.09 | -$0.12 | -$0.17 | -- | -$0.27 | -$0.51 | -$0.80 | -$0.81 |
| Basic Shares Outstanding | 72.6M | 72.4M | 72.3M | -- | 59.8M | 40.6M | 36.6M | 36.3M |
| Diluted Shares Outstanding | 72.6M | 72.4M | 72.3M | -- | 59.8M | 40.6M | 36.6M | 36.3M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $55.81M | $58.28M | $176.9M | $111.9M | $145.7M | $61.70M |
| Short-Term Investments | -- | -- | -- | $1.15M | $27.78M | -- |
| **Cash & Short-Term Investments** | $55.81M | $58.28M | $176.9M | $113.0M | $173.5M | $61.70M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | $16K |
| Other Current Assets | -- | -- | -- | -- | -- | $29K |
| **Total Current Assets** | $58.05M | $68.33M | $179.2M | $117.8M | $176.6M | $62.22M |
| Property, Plant & Equipment, Net | $153K | $3.77M | $5.16M | $5.84M | $2.96M | $81K |
| Long-Term Investments | -- | -- | -- | -- | $1.88M | -- |
| Other Non-Current Assets | $0 | $619K | $5.50M | $3.15M | $1.23M | $12K |
| **Total Non-Current Assets** | $522K | $11.61M | $20.75M | $11.49M | $9.14M | $303K |
| **Total Assets** | $58.57M | $79.94M | $199.9M | $129.3M | $185.7M | $62.53M |
| Accounts Payable | $3.23M | $12.93M | $6.85M | $6.83M | $1.33M | $727K |
| Other Current Liabilities | $169K | $203K | $192K | $636K | $480K | -- |
| **Total Current Liabilities** | $11.10M | $21.67M | $22.86M | $19.10M | $4.64M | $1.62M |
| **Total Non-Current Liabilities** | $17.92M | $6.69M | $7.83M | $1.67M | $2.29M | $0 |
| **Total Liabilities** | $29.02M | $28.36M | $30.69M | $20.77M | $6.92M | $1.62M |
| **Total Debt (incl. Leases)** | $1.59M | $8.77M | $10.30M | $2.29M | $2.85M | $223K |
| Common Stock | $7.0K | $4.0K | $4.0K | $3.0K | $3.0K | $1.0K |
| Retained Earnings | -$449.0M | -$387.3M | -$248.8M | -$131.6M | -$49.74M | -$8.18M |
| Accumulated Other Comp. Income | -- | -- | -- | -$1.0K | -$10K | -- |
| **Total Stockholders' Equity** | $29.55M | $51.57M | $169.2M | $108.5M | $178.8M | $5.17M |
| Total Equity | $29.55M | $51.57M | $169.2M | $108.5M | $178.8M | $5.17M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $26.40M | $34.82M | $44.69M | $55.81M | $46.64M | $56.22M | $35.86M | $58.28M |
| **Cash & Short-Term Investments** | $26.40M | $34.82M | $44.69M | $55.81M | $46.64M | $56.22M | $35.86M | $58.28M |
| **Total Current Assets** | $27.66M | $36.43M | $46.32M | $58.05M | $49.44M | $64.66M | $44.69M | $68.33M |
| Property, Plant & Equipment, Net | $37K | $47K | $47K | $153K | $200K | $2.83M | $3.30M | $3.77M |
| Other Non-Current Assets | $398K | $398K | -- | $0 | $0 | $4.0K | $617K | $619K |
| **Total Non-Current Assets** | $435K | $445K | $67K | $522K | $5.75M | $8.50M | $10.37M | $11.61M |
| **Total Assets** | $28.10M | $36.87M | $46.38M | $58.57M | $55.19M | $73.16M | $55.05M | $79.94M |
| Accounts Payable | $3.26M | $3.31M | $4.61M | $3.23M | $6.40M | $8.38M | $7.71M | $12.93M |
| Other Current Liabilities | $144K | $191K | $159K | $169K | $144K | $210K | $261K | $203K |
| **Total Current Liabilities** | $12.77M | $10.48M | $9.29M | $11.10M | $15.56M | $17.57M | $19.82M | $21.67M |
| **Total Non-Current Liabilities** | $7.74M | $14.25M | $18.37M | $17.92M | $24.00M | $28.09M | $6.50M | $6.69M |
| **Total Liabilities** | $20.51M | $24.74M | $27.67M | $29.02M | $39.57M | $45.65M | $26.32M | $28.36M |
| **Total Debt (incl. Leases)** | $506K | $877K | $1.24M | $1.59M | $6.88M | $7.05M | $7.93M | $8.77M |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $4.0K | $4.0K |
| Retained Earnings | -$476.0M | -$469.8M | -$461.5M | -$449.0M | -$453.7M | -$437.3M | -$416.5M | -$387.3M |
| **Total Stockholders' Equity** | $7.59M | $12.14M | $18.72M | $29.55M | $15.62M | $27.51M | $28.74M | $51.57M |
| Total Equity | $7.59M | $12.14M | $18.72M | $29.55M | $15.62M | $27.51M | $28.74M | $51.57M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$61.80M | -$138.4M | -$117.3M | -$81.83M | -$41.57M | -$5.32M | -$1.20M |
| Depreciation & Amortization | $1.41M | $1.75M | $1.51M | $691K | $249K | $8.0K | $0 |
| Stock-Based Compensation | $9.52M | $19.09M | $14.13M | $10.34M | $6.23M | $322K | -- |
| Change in Payables | -$9.70M | $6.09M | $2.56M | $2.96M | $640K | $418K | -$98K |
| **Operating Cash Flow** | -$70.37M | -$119.9M | -$96.59M | -$62.42M | -$35.44M | -$4.46M | -$1.28M |
| Capital Expenditure | -- | -$362K | -$3.37M | -$1.03M | -$3.17M | -$51K | -- |
| **Free Cash Flow** | -- | -$120.3M | -$99.96M | -$63.45M | -$38.61M | -$4.51M | -- |
| Purchases of Investments | -- | -- | -- | -- | -$38.49M | -- | -- |
| Sales & Maturities of Investments | -- | -- | $1.15M | $28.37M | $8.31M | -- | -- |
| **Investing Cash Flow** | -- | -$362K | -$2.22M | $27.34M | -$33.35M | -$51K | -- |
| Common Stock Issued | $4.91M | -- | $161.8M | -- | -- | $10.19M | $1.44M |
| **Financing Cash Flow** | $67.90M | $1.67M | $163.8M | $1.24M | $153.2M | $65.97M | $1.44M |
| **Net Change in Cash** | -$2.47M | -$118.6M | $64.99M | -$33.84M | $84.39M | $61.46M | $161K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.18M | -$8.33M | -$12.41M | $4.61M | -$16.41M | -$20.74M | -$29.26M | -$29.30M |
| Depreciation & Amortization | $10K | $20K | $46K | $47K | $400K | $500K | $468K | $469K |
| Stock-Based Compensation | $1.62M | $1.59M | $1.58M | $1.84M | $1.94M | $2.57M | $3.17M | $4.49M |
| Change in Payables | -$46K | -$1.31M | $1.38M | -$3.17M | -$1.83M | $517K | -$5.22M | $4.02M |
| **Operating Cash Flow** | -$8.43M | -$10.03M | -$11.67M | -$13.94M | -$11.55M | -$19.21M | -$25.67M | -$30.00M |
| Capital Expenditure | -- | -- | -- | -- | $0 | $0 | $0 | -$82K |
| **Free Cash Flow** | -- | -- | -- | -- | -$11.55M | -$19.21M | -$25.67M | -$30.09M |
| **Investing Cash Flow** | $0 | $0 | $550K | -- | $0 | $0 | $0 | -$82K |
| Common Stock Issued | -- | -- | -- | -$124K | $0 | $1.77M | $3.26M | -- |
| **Financing Cash Flow** | -- | -- | -- | $23.11M | $1.97M | $39.57M | $3.25M | $413K |
| **Net Change in Cash** | -$8.42M | -$9.87M | -$11.12M | $9.17M | -$9.58M | $20.36M | -$22.41M | -$29.67M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -209.1% | -268.4% | -69.3% | -75.4% | -23.2% | -103.0% | -- |
| Return on Assets (ROA) | -105.5% | -173.2% | -58.6% | -63.3% | -22.4% | -8.5% | -- |
| Current Ratio | 5.23x | 3.15x | 7.84x | 6.17x | 38.08x | 38.43x | -- |
| Quick Ratio | 5.03x | 2.69x | 7.74x | 5.92x | 37.42x | 38.12x | -- |
| Debt to Equity | 0.05x | 0.17x | 0.06x | 0.02x | 0.02x | 0.04x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -294.1% | -268.1% | -240.1% | -209.1% | -612.8% | -407.5% | -447.6% | -268.4% |
| Return on Assets (ROA) | -79.4% | -88.2% | -96.9% | -105.5% | -173.4% | -153.2% | -233.6% | -173.2% |
| Current Ratio | 2.17x | 3.47x | 4.98x | 5.23x | 3.18x | 3.68x | 2.25x | 3.15x |
| Quick Ratio | 2.07x | 3.32x | 4.81x | 5.03x | 3.00x | 3.20x | 1.81x | 2.69x |
| Debt to Equity | 0.07x | 0.07x | 0.07x | 0.05x | 0.44x | 0.26x | 0.28x | 0.17x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
